alpha labs retatrutide (RETA) – Research Peptide Retatrutide (GLP-3) Research Peptide |

Rare in the trials, but a recognised concern with GLP-1 medications generally, partly because rapid weight loss itself can trigger gallstones

Espaol Esta pgina web acaba de ser activada y an no tiene contenido

PMID: 9094161

GLP-1 receptor agonists increase serotonin turnover in the brain, meaning more serotonin is being released, utilized, and recycled

These prespecified analyses considered factors such as age, hypertension, heart failure, eGFR, proteinuria, new users after the index day, enrollee after 2006 and concurrent usage of other medications for glycemic control, and renin-angiotensin-aldosterone system (RAAS) blockers